Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Fujirebio Inc.

Division of Miraca Holdings Inc.

Latest From Fujirebio Inc.

Unsuccessful IPOs

Not all initial public offerings are taken up, even in the best of funding years. Of the 54 life sciences IPOs registered in 1997, 11 (20%) were withdrawn because of pricing issues or lack of interest.

BioPharmaceutical Deals

Fujirebio snaps up offloaded Abbott diagnostics unit

The Japanese firm Fujirebio is to pay ¥9.8 billion ($112.9 million) for Innogenetics, a Belgian diagnostics and biologics operation acquired by Abbott as part of the US firm's broader purchase of Solvay Pharmaceuticals earlier this year.

Brazil Deals

Clinical Edge

Brief summaries of recent advances in device research and clinical trials, including a new study sugesting that treating post-PCI patients with vascular closure devices in combination with bivalirudin have substantially reduced bleeding rates, and a large study of postmeenopausal women indicated that tracking CA-125 may be an effective way to detect early-stage ovarian cancer.
Medical Device

Roche/Chugai Blaze a Trail...But Will Anyone Follow?

Roche and Chugai have entered new dealmaking territory. This is the first time a Western company has taken over a Japanese counterpart in one go, and on a friendly basis. The deal grants Chugai enough independence for it to save face, while allowing Roche to leapfrog into the top ten in Japan. As such, the deal should in theory provide a template for others. But in Japan few CEOs are as open-minded as Chugai's leader. Equally, few Western companies can boast Roche's aptitude for arm's-length management.
BioPharmaceutical North America
See All

Company Information